These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

209 related items for PubMed ID: 11083774

  • 1. Isolation and characterization of a Shigella flexneri invasin complex subunit vaccine.
    Turbyfill KR, Hartman AB, Oaks EV.
    Infect Immun; 2000 Dec; 68(12):6624-32. PubMed ID: 11083774
    [Abstract] [Full Text] [Related]

  • 2. Development and evaluation of a Shigella flexneri 2a and S. sonnei bivalent invasin complex (Invaplex) vaccine.
    Oaks EV, Turbyfill KR.
    Vaccine; 2006 Mar 20; 24(13):2290-301. PubMed ID: 16364513
    [Abstract] [Full Text] [Related]

  • 3. Assembly, Biochemical Characterization, Immunogenicity, Adjuvanticity, and Efficacy of Shigella Artificial Invaplex.
    Turbyfill KR, Clarkson KA, Vortherms AR, Oaks EV, Kaminski RW.
    mSphere; 2018 Mar 20; 3(2):. PubMed ID: 29600284
    [Abstract] [Full Text] [Related]

  • 4. Immunogenicity and efficacy of highly purified invasin complex vaccine from Shigella flexneri 2a.
    Turbyfill KR, Kaminski RW, Oaks EV.
    Vaccine; 2008 Mar 04; 26(10):1353-64. PubMed ID: 18276045
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Evaluation of immunogenicity and protective efficacy of orally delivered Shigella type III secretion system proteins IpaB and IpaD.
    Heine SJ, Diaz-McNair J, Martinez-Becerra FJ, Choudhari SP, Clements JD, Picking WL, Pasetti MF.
    Vaccine; 2013 Jun 19; 31(28):2919-29. PubMed ID: 23644075
    [Abstract] [Full Text] [Related]

  • 7. Development and preclinical evaluation of a trivalent, formalin-inactivated Shigella whole-cell vaccine.
    Kaminski RW, Wu M, Turbyfill KR, Clarkson K, Tai B, Bourgeois AL, Van De Verg LL, Walker RI, Oaks EV.
    Clin Vaccine Immunol; 2014 Mar 19; 21(3):366-82. PubMed ID: 24403527
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Antibody response of monkeys to invasion plasmid antigen D after infection with Shigella spp.
    Oaks EV, Picking WD, Picking WL.
    Clin Diagn Lab Immunol; 1996 Mar 19; 3(2):242-5. PubMed ID: 8991646
    [Abstract] [Full Text] [Related]

  • 12. Safety and immunogenicity of a Shigella flexneri 2a Invaplex 50 intranasal vaccine in adult volunteers.
    Tribble D, Kaminski R, Cantrell J, Nelson M, Porter C, Baqar S, Williams C, Arora R, Saunders J, Ananthakrishnan M, Sanders J, Zaucha G, Turbyfill R, Oaks E.
    Vaccine; 2010 Aug 23; 28(37):6076-85. PubMed ID: 20619378
    [Abstract] [Full Text] [Related]

  • 13. Characterization of a novel fusion protein from IpaB and IpaD of Shigella spp. and its potential as a pan-Shigella vaccine.
    Martinez-Becerra FJ, Chen X, Dickenson NE, Choudhari SP, Harrison K, Clements JD, Picking WD, Van De Verg LL, Walker RI, Picking WL.
    Infect Immun; 2013 Dec 23; 81(12):4470-7. PubMed ID: 24060976
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. IpaD-loaded N-trimethyl Chitosan Nanoparticles Can Efficiently Protect Guinea Pigs against Shigella flexneri.
    Akbari MR, Saadati M, Honari H, Ghorbani HM.
    Iran J Immunol; 2019 Sep 23; 16(3):212-224. PubMed ID: 31552830
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. IpaD of Shigella flexneri is independently required for regulation of Ipa protein secretion and efficient insertion of IpaB and IpaC into host membranes.
    Picking WL, Nishioka H, Hearn PD, Baxter MA, Harrington AT, Blocker A, Picking WD.
    Infect Immun; 2005 Mar 23; 73(3):1432-40. PubMed ID: 15731041
    [Abstract] [Full Text] [Related]

  • 18. Protein-protein interactions in the assembly of Shigella flexneri invasion plasmid antigens IpaB and IpaC into protein complexes.
    Davis R, Marquart ME, Lucius D, Picking WD.
    Biochim Biophys Acta; 1998 Dec 08; 1429(1):45-56. PubMed ID: 9920383
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.